Polycystic ovary syndrome (PCOS) is a common endocrine disorder with heterogenous clinical manifestations. The evidence indicates that PCOS is associated with long-term …
Z Chang, G Deng, Y Shao, D Xu, Y Zhao… - Frontiers in …, 2021 - frontiersin.org
Background: Emerging evidence suggests that gut microbiota plays a vital role in the occurrence of multiple endocrine disorders including polycystic ovary syndrome (PCOS) …
S Cauci, S Xodo, C Buligan, C Colaninno, M Barbina… - Molecules, 2021 - mdpi.com
Information concerning the mechanisms underlying oxidative stress and low-grade inflammation in young healthy women predisposing eventually to future diseases is scarce …
Aim To investigate risk of thyroid disease in Danish women with PCOS. Design National register-based study on women with PCOS in Denmark. 18,476 women had a diagnosis of …
Hormonal contraceptives are widely used for birth control and for the treatment of symptoms related to polycystic ovary syndrome (PCOS), such as menstrual irregularities, hirsutism and …
J Yu, Y Zhou, J Ding, D Zhang, C Yu… - Frontiers in …, 2023 - frontiersin.org
Background Polycystic ovary syndrome (PCOS) is a kind of endocrine and metabolic disorder, disturbing the females of reproductive age. Here, we aimed to investigate the …
S Aksun, E Ersal, O Portakal, BO Yildiz - Endocrine, 2023 - Springer
Purpose Polycystic ovary syndrome (PCOS) is associated with alterations in gut microbiota. The cytokine interleukin-22 (IL-22) is produced by immune cells and closely linked to gut …
SF de Medeiros, JMS Junior, MAS de Medeiros… - Archives of Gynecology …, 2024 - Springer
Background Polycystic ovary syndrome (PCOS) is a heterogenous endocrine condition and combined oral contraceptives (COCs) have been demonstrated to be the first-line treatment …